View Older Stories View More Recent Stories
-
Mogotes Metals Drills 180 m at 0.98% Copper Equivalent, Expanding the Albor Copper-Gold-Silver-Molybdenum Discovery at Filo Sur, Vicuna District
-
West Point Gold Intersects 56.4m of 4.24 g/t Au, Widening the High-Grade Zone at Depth
-
Legend Power Announces Multiple Public-Sector SmartGATE Orders Addressing Facility Operating and Capital Cost Risk
-
North Valley Resources Expands Previously Announced Private Placement to $1.7 Million with Addition of Critical Mineral Flow-Through Shares
-
Graycliff Exploration Uplisted to OTCQB Venture Market
-
DCM Announces Strategic Acquisition of Octacom, Strengthening Its Position in High-Growth Intelligent Document Processing Market
-
Telo Genomics Files Patent to Expand IP Portfolio to Liquid Biopsy MRD Applications for Multiple Myeloma
-
Intrepid Metals Advances Porphyry Targeting at Corral Ahead of Integrated Geophysical Survey and Planned Q3 Drill Program
-
Besra Gold Responds to the Purported Notices Under s.143 of CBCA
-
TempraMed Expands Institutional Healthcare Network with Meuhedet Health Services, a Leading HMO in Israel, Covering over 1 Million Lives
-
Roxmore Resources Reports Strong Drill Results at the Converse Gold Project, Battle Mountain - Eureka Trend Nevada
-
KKR launches Allyntra, a precision-engineered medtech platform
-
Spotify (SPOT) PT Lowered to $531 at Rosenblatt
-
Bernstein sees higher gold prices in H2’26, sets new price target
-
Jones Trading Starts Flotek Industries (FTK) at Buy
-
Arete Downgrades Paramount Skydance (PSKY) to Sell
-
Par Pacific Holdings (PARR) PT Raised to $80 at Mizuho
-
Rockwell Medical Technologies (RMTI) PT Raised to $20 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on CervoMed (CRVO)
-
Northland Starts Cohen & Company (COHN) at Outperform
-
Satellos Bioscience Inc. (MSLE) PT Raised to $18 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on Niagen Bioscience (NAGE)
-
Northland Upgrades Better Home & Finance Holding (BETR) to Outperform
-
H.C. Wainwright Reiterates Buy Rating on Vanda Pharmaceuticals (VNDA)
-
Helus Pharma (HELP) PT Lowered to $70 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on Terra Innovatum Global (NKLR)
-
Buckle reports 5.2% net sales rise for fiscal June 2026
-
H.C. Wainwright Reiterates Buy Rating on First Tracks Biotherapeutics (TRAX)
-
DISC Plus Profiles: Why More HR Teams Use Behavioral and DISC Assessments to Reduce Costly Hiring Mistakes
-
H.C. Wainwright Reiterates Buy Rating on Compass Pathways (CMPS)
-
H.C. Wainwright Reiterates Buy Rating on UroGen Pharma (URGN)
-
H.C. Wainwright Reiterates Buy Rating on Immunome Inc. (IMNM)
-
Goldman Sachs Downgrades Mattel Inc. (MAT) to Sell
-
H.C. Wainwright Reiterates Buy Rating on Tarsus Pharmaceuticals (TARS)
-
Goldman: 'Our top picks include XYZ, KLAR, AFRM, and CHYM'
-
Enliven Therapeutics (ELVN) PT Raised to $65 at H.C. Wainwright
-
Goldman Sachs Upgrades Toast Inc. (TOST) to Buy
-
Coinbase investigates prediction markets trading issue
-
H.C. Wainwright Starts Polaryx Therapeutics (PLYX) at Buy
-
Volkswagen labor union vows to fight factory closures
-
Expeditors Int'l (EXPD) PT Raised to $191 at UBS
-
Cantor Fitzgerald Starts HCI Group (HCI) at Overweight
-
Cantor Fitzgerald Starts Merlin Labs (MRLN) at Overweight
-
Cantor Fitzgerald Starts Velo3D (VELO) at Overweight
-
Needham Assumes Centrus Energy Corp. (LEU) at Buy
-
Oppenheimer Reiterates Perform Rating on D.R. Horton (DHI)
-
Cantor Fitzgerald Upgrades American International Group (AIG) to Overweight
-
Starbucks working on AI tools to replace Microsoft and IBM software - report
-
Vortex Metals names new president, launches C$1M private placement
-
XCF Global starts renewable diesel output at Reno facility
